The New York State Psychiatric Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1895-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.nyspi.org
Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 150
- Registration Number
- NCT00249483
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 86
- Registration Number
- NCT00249444
- Locations
- 🇺🇸
Research Foundation for Mental Hygiene, Inc., New York, New York, United States
Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder
Not Applicable
Completed
- Conditions
- Depression
- Interventions
- Behavioral: Culturally Congruent Assessment and Treatment
- First Posted Date
- 2005-11-01
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 113
- Registration Number
- NCT00247195
- Locations
- 🇺🇸
New York State Psychiatric Institute - Hispanic Treatment Program, New York, New York, United States
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
Phase 2
Completed
- Conditions
- Heroin Dependence
- Interventions
- Behavioral: Compliance Enhancement (CE)Behavioral: Behavioral Naltrexone Therapy (BNT)
- First Posted Date
- 2005-10-14
- Last Posted Date
- 2012-01-13
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 12
- Registration Number
- NCT00238914
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
Phase 4
Completed
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Behavioral: Cognitive Behavioral Therapy
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-12-19
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 25
- Registration Number
- NCT00219349
- Locations
- 🇺🇸
Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, New York, United States
Dronabinol Treatment for Marijuana Addiction
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 156
- Registration Number
- NCT00217971
- Locations
- 🇺🇸
Research Foundation for Mental Hygiene, Inc., New York, New York, United States
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2
Completed
- Conditions
- Attention Deficit Disorder With HyperactivityCocaine-Related Disorders
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00218543
- Locations
- 🇺🇸
Research Foundation for Mental Hygiene, Inc., New York, New York, United States
Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
Phase 3
Completed
- Conditions
- Marijuana AbuseAttention Deficit and Disruptive Behavior Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 25
- Registration Number
- NCT00218114
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
Phase 1
Terminated
- Conditions
- Coronary Artery Disease (CAD)DepressionAcute Coronary Syndrome (ACS)
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 7
- Registration Number
- NCT00208117
- Locations
- 🇺🇸
Columbia University Department of General Medicine, New York, New York, United States
Prescription Opioid Effects in Abusers Versus Non-Abusers
Phase 2
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2017-07-07
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 27
- Registration Number
- NCT00158184
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath